JEFFRY J. HOWBERT,MURALIKRISHNA DUVVURI,ROB HERSHBERG,GREG DIETSCH
申请号：
PT09803657
公开号：
PT2313111E
申请日:
2009.07.31
申请国别(地区):
PT
年份:
2013
代理人:
摘要：
The present invention is directed generally to stable formulations of a TLR agonist preferably a TLR7 or a TLR8 agonist, for use in the treatment of cancer, preferably solid tumors and lymphomas. Specifically, the present invention is directed to stable formulations of up to 50 mg/ml of a TLR agonist which comprise a cyclodextrin.
